SEC Filing Summary: Exegenics Inc. (8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Exegenics Inc. on October 24, 2002. The registrant is incorporated in Delaware with principal executive offices in Dallas, Texas. The report addresses a specific corporate event regarding the listing status of the company's common stock.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a listing transfer event and does not contain financial statements or performance data.
Material Changes
- Listing Transfer: The company received approval from The Nasdaq Stock Market to transfer the listing of its common stock from the Nasdaq National Market to the Nasdaq SmallCap Market.
- Effective Date: The transfer became effective at the opening of trading on October 25, 2002.
Outlook, Risks, and Management Commentary
Management announced the listing transfer via a press release dated October 24, 2002, which is filed as Exhibit 99.1. The filing does not contain forward-looking guidance, specific risk factors, or commentary on contingencies beyond the administrative change in market listing.
Investor Verification Checklist
- Verify the effective date of the listing transfer (October 25, 2002).
- Confirm the new trading venue (Nasdaq SmallCap Market).
- Review the attached press release (Exhibit 99.1) for any additional context regarding the reasons for the transfer.
- Note that this filing does not contain financial performance data; refer to the most recent 10-K or 10-Q for financial metrics.